Insulin-dependent diabetes mellitus (IDDM) is the most common autoimmune disease in humans and its incidence is rising. We have developed molecular tools to study some fundamental aspects of the mechanisms leading to self-reactivity during the first 5 years of this grant. Our effort will be pursued along the same lines. From a structural perspective, the priority will be on achieving the x-ray structureI determination of at least one I-Ag7/TCR complex. Effort will be put into the development of more efficient protein expression systems and the development of single chain FV versions of soluble TCRs. These structures together with measurements of the affinity of self-reactive TCRs for their self-peptide MHC ligands will allow us to understand the role that TCR/MHC interaction may play in the selection and expansion of autoreactive T cells. Structural studies will also be the basis to investigate the role of the anionic P9 pocket of the I-Ag7 molecule on the selection of TCRs with acidic residues within their CDR2a and CDR3b regions, whenever charge complementation is not provided by the peptide. This hypothesis will be tested in the NOD mouse using immunization with variant peptides and TCR sequencing. Recombinant MHC will also be used to produce multimeric reagents able to detect antigen-specific CD4+ T cells in naive NOD using natural peptides (from GAD and insulin) and mimotopes reactive to diabetogenic T cell clones. The initial characterization of the natural BDC2.5-reactive population, that was identified using this approach, will be extended further with quantitative cytokine profiling, single cell TCR analysis and in vivo transfer experiments. A similar strategy will be used to try to identify an equivalent T cell population in HLA-DQ8 transgenic mice and in human using HLA-DQ8 -mimotope multimers. Further improvements of the MHC tetramer technology will be pursued using newer protein engineering techniques to try to obtain a reliable, sensitive technique fit to clinical settings for the detection of pathogenic CD4+ T cells in blood. Finally, we will also use multimerized recombinant MHC molecules to try therapeutic targeting of the BDC2.5+ antigen-specific T cells in the NOD. Efficacy will be appreciated by measuring BDC2.5+ cells using FACS and glucose levels during the course of treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK055037-07
Application #
6858558
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Spain, Lisa M
Project Start
1999-01-01
Project End
2008-11-30
Budget Start
2004-12-01
Budget End
2005-11-30
Support Year
7
Fiscal Year
2005
Total Cost
$521,994
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Yoshida, Kenji; Corper, Adam L; Herro, Rana et al. (2010) The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J Clin Invest 120:1578-90
Landais, Elise; Romagnoli, Pablo A; Corper, Adam L et al. (2009) New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation. J Immunol 183:7949-57
Depaolo, R William; Tang, Fangming; Kim, Inyoung et al. (2008) Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 4:350-61
Hovhannisyan, Zaruhi; Weiss, Angela; Martin, Alexandra et al. (2008) The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456:534-8
Homann, Dirk; Lewicki, Hanna; Brooks, David et al. (2007) Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II. Virology 363:113-23
Brooks, David G; Teyton, Luc; Oldstone, Michael B A et al. (2005) Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol 79:10514-27
Ranheim, Erik A; Tarbell, Kristin V; Krogsgaard, Michelle et al. (2004) Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene. Autoimmunity 37:555-67
Robey, Ian F; Peterson, Melissa; Horwitz, Marc S et al. (2004) Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice. J Immunol 172:4624-9
Stratmann, Thomas; Martin-Orozco, Natalia; Mallet-Designe, Valerie et al. (2003) Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J Clin Invest 112:902-14
Mallet-Designe, Valerie I; Stratmann, Thomas; Homann, Dirk et al. (2003) Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response. J Immunol 170:123-31

Showing the most recent 10 out of 17 publications